Antibiotic prophylaxis for transrectal needle biopsy of the prostate: A randomized controlled study

BJU International

Volumn 85, Issue 6, 2000, Pages 682-685

  Aron, M ^a   Rajeev, T P ^a   Gupta, N P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antibiotic; Biopsy; Complications; Prophylaxis; Prostate

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; ENEMA; TINIDAZOLE;

AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HEMATURIA; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PAIN; PRIORITY JOURNAL; PROSTATE BIOPSY; RANDOMIZED CONTROLLED TRIAL; RECTUM HEMORRHAGE; SCHOOL CHILD; SYMPTOM; URINARY TRACT; URINE CULTURE;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BIOPSY, NEEDLE; CHI-SQUARE DISTRIBUTION; CIPROFLOXACIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC DISEASES; TINIDAZOLE; URINARY TRACT INFECTIONS;

EID: 0034025951     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00576.x     Document Type: Article

References (26)

1. 1 Hodge KK, McNeal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol 1989; 142: 66-70
2. 2 Vallancien G, Prapotnich D, Veillon B, Brisset JM, Andre-Bougaran J. Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol 1991; 146: 1308-12
3. 3 Aus G, Hermansson CG, Hugosson J, Pedersen KV. Transrectal ultrasound examination of the prostate: complications and acceptance by patients. Br J Urol 1993; 71: 457-9
4. 4 Desmond PM, Clark J, Thompson IM, Zeidman EJ, Mueller EJ. Morbidity with contemporary prostate biopsy. J Urol 1993; 150: 1425-6
5. 5 Norberg M, Holmberg L, Häggman M, Magnusson A. Determinants of complications after multiple transrectal core biopsies of the prostate. Acta Radiol Suppl 1994; 35: 7-21
6. 6 Aus G, Ahlgren G, Bergdahl S, Hugosson J. Infection after transrectal core biopsies of the prostate-risk factors and antibiotic prophylaxis. Br J Urol 1996; 77: 851-5
7. 7 Collins GN, Lloyd SN, Hehir M, McKelvie GB. Multiple transrectal ultrasound-guided prostatic biopsies - true morbidity and patient acceptance. Br J Urol 1993; 71: 460-3
8. 8 Devonec M, Fendler JP, Monsallier M et al. The significance of the prostatic hypoechoic area: Results in 226 ultrasonically guided prostatic biopsies. J Urol 1990; 143: 316-9
9. 9 Hammerer P, Huland H. Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol 1994; 151: 99-102
10. 10 Cooner WH, Mosley BR, Rutherford CL et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 1990; 143: 1146-54
11. 11 Cooner WH, Mosley BR, Rutherford CL et al. Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer. J Urol 1988; 139: 758-61
12. 12 Vallancien G, Prapotnich D, Sibert L et al. Comparison of the efficacy of digital ractal examination and tansrectal ultrasonography in the diagnosis of prostate cancer. Eur Urol 1989; 16: 321-4
13. 13 Torp-Pedersen S, Lee F, Littrup PJ et al. Transrectal biopsy of the prostate guided with transrectal US. longitudinal and multiplanar scanning. Radiology 1989; 170: 23-7
14. 14 Kilner SV, Woo HH, Rosario DJ, Chapple CR, Anderson JB. Morbidity of transrectal ultrasound and systematic sextant prostatic biopsies. J Urol 1995; 153: 986(Abstract)
15. 15 Gustavsson O, Norming U, Nyman CR, Ohrstrom M. Complications following combined transrectal aspiration and core biopsy of the prostate. Scand J Urol Nephrol 1990; 24: 249-51
16. 16 Enlund A-L, Varenhorst E. Morbidity of ultrasound guided transrectal core biopsy of the prostate without antibiotic therapy. A prospective study in 415 cases. Br J Urol 1997; 79: 777-80
17. 17 Rosai J. Male reproductive system. In Ackerman's Surgical Pathology. 8th edn, Vol 1. St Louis: Mosby-Year Book Inc., 1996: 1224
18. 18 Astraldi A. Diagnosis of cancer of the prostate: biopsy by rectal route. Urol Cutaneous Rev 1937; 41: 421
19. 19 Wendel RG, Evans AT. Complications of punch biopsy of the prostate gland. J Urol 1967; 97: 122
20. 20 Davison P, Malament M. Urinary contamination as a result of transrectal biopsy of the prostate. J Urol 1971; 105: 545
21. 21 Crawford ED, Haynes AL, Story MW et al. Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. J Urol 1982; 127: 449
22. 22 Thompson PM, Pryor JP, Williams JP et al. The problem of infection after prostatic biopsy: the case for the transperineal approach. Br J Urol 1982; 54: 736
23. 23 Fong IW, Struther N, Honey RJ et al. A randomized comparative study of the prophylactic use of trimethoprim-sulfamethoxazole versus netilmycin-metronidazole intransrectal prostatic biopsy. J Urol 1991; 146: 794
24. 24 Breslin JA, Turner BI, Faber RB. Anaerobic infection as a consequence of transrectal prostatic biopsy. J Urol 1978; 120: 502-3
25. 25 Mandell GL, Petri Wa Jr. Title? In Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. Goodman and Gillman's: The Pharmacological Basis of Therapeutics, 9th edn. New York: McGraw-Hill, 1996: 1065-8
26. 26 Kucers A, Crowe SM, Grayson ML, Hoy JF. Tinidazole. In The Use of Antibiotics: a Clinical Review of Antibacterial, Antifungal and Antiviral Drugs, 5th edn. Oxford: Butterworth Heinemann 1997: 959-64